Compare BioNTech SE - ADR (BNTX) vs Norfolk Southern Corporation (NSC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Norfolk Southern Corporation — how do they compare? BioNTech SE - ADR trades at $90.28 (market cap $22.86B), while Norfolk Southern Corporation trades at $325.6 (market cap $73.40B). The key difference: Norfolk Southern Corporation is far larger — about 3.2× BioNTech SE - ADR's market cap, and Norfolk Southern Corporation pays a 1.65% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | NSC | |
|---|---|---|
Market Cap | $22.86B | $73.40B |
Sector | Health | Technology |
52-Week High | $119.34 | $327.59 |
52-Week Low | $83.89 | $259.49 |
Enterprise Value | $6.53B | $89.16B |
Dividend Yield | — | 1.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Norfolk Southern (NSC) trades at $327.59, up 0.04% on the day, with a bullish technical outlook driven by moving averages and a consensus price target of $344.40. The stock has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on July 23, 2026. Strong profitability is evident with a 21.91% net income margin and 17.6% ROE, though valuation multiples like a P/E of 27.53 are elevated. Recent news highlights the ongoing merger review with Union Pacific, a key regulatory focus.
NSC offers steady earnings growth and dividend income, but risks include regulatory hurdles for the merger and rich valuations limiting near-term upside. Analyst sentiment is mixed with 44% buy ratings, suggesting cautious optimism amid merger uncertainty. The stock's proximity to its 52-week high warrants monitoring for pullbacks to support levels near $323.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →
